New biochemical markers of aortic dissection

C. Cola, S. Trimarchi, A. Mauriello, K. A. Eagle, Giuseppe Sangiorgi

Research output: Contribution to journalArticle

Abstract

The incidence of aortic dissection (AD) ranges from 5 to 30 cases per million people per year. Although the disease is uncommon, its outcome is frequently rapidly fatal. Consequently, the challenge in management of acute AD lies in early diagnosis and timely therapy. Unfortunately, clinical presentation is often misleading: physical findings may be absent or, if present, could be suggestive of other conditions, and therefore the correct diagnosis is missed in up to 40% of patients on initial clinical evaluation. Different diagnostic modalities are now available to improve aortic dissection detection. Spiral CT scanning, MRI and transoesophageal echocardiography are accurate modalities to detect AD with different sensitivity and specificity, but each of these techniques has potential limitations in the evaluation of different clinical-morphological presentation of the disease. Routine laboratory tests have been marginally used so far for AD diagnosis, mostly for differential diagnosis (i.e. myocardial specific enzymes for the exclusion of acute myocardial infarction). Recently, several serum biochemical markers for AD diagnosis and follow-up have been proposed; they may be very useful in association with established imaging tools to improve rapid diagnosis and, consequently, outcome. In this review, we will illustrate the most recent proposed biomarkers, their clinical usefulness and future implications for their utilisation.

Original languageEnglish
Pages (from-to)66-70
Number of pages5
JournalCardiology International
Volume7
Issue number2
Publication statusPublished - Jun 2006

Fingerprint

Dissection
Biomarkers
Spiral Computed Tomography
Transesophageal Echocardiography
Early Diagnosis
Differential Diagnosis
Myocardial Infarction
Sensitivity and Specificity
Incidence
Enzymes
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cola, C., Trimarchi, S., Mauriello, A., Eagle, K. A., & Sangiorgi, G. (2006). New biochemical markers of aortic dissection. Cardiology International, 7(2), 66-70.

New biochemical markers of aortic dissection. / Cola, C.; Trimarchi, S.; Mauriello, A.; Eagle, K. A.; Sangiorgi, Giuseppe.

In: Cardiology International, Vol. 7, No. 2, 06.2006, p. 66-70.

Research output: Contribution to journalArticle

Cola, C, Trimarchi, S, Mauriello, A, Eagle, KA & Sangiorgi, G 2006, 'New biochemical markers of aortic dissection', Cardiology International, vol. 7, no. 2, pp. 66-70.
Cola C, Trimarchi S, Mauriello A, Eagle KA, Sangiorgi G. New biochemical markers of aortic dissection. Cardiology International. 2006 Jun;7(2):66-70.
Cola, C. ; Trimarchi, S. ; Mauriello, A. ; Eagle, K. A. ; Sangiorgi, Giuseppe. / New biochemical markers of aortic dissection. In: Cardiology International. 2006 ; Vol. 7, No. 2. pp. 66-70.
@article{00875de3e2e44adf8e8668c322587767,
title = "New biochemical markers of aortic dissection",
abstract = "The incidence of aortic dissection (AD) ranges from 5 to 30 cases per million people per year. Although the disease is uncommon, its outcome is frequently rapidly fatal. Consequently, the challenge in management of acute AD lies in early diagnosis and timely therapy. Unfortunately, clinical presentation is often misleading: physical findings may be absent or, if present, could be suggestive of other conditions, and therefore the correct diagnosis is missed in up to 40{\%} of patients on initial clinical evaluation. Different diagnostic modalities are now available to improve aortic dissection detection. Spiral CT scanning, MRI and transoesophageal echocardiography are accurate modalities to detect AD with different sensitivity and specificity, but each of these techniques has potential limitations in the evaluation of different clinical-morphological presentation of the disease. Routine laboratory tests have been marginally used so far for AD diagnosis, mostly for differential diagnosis (i.e. myocardial specific enzymes for the exclusion of acute myocardial infarction). Recently, several serum biochemical markers for AD diagnosis and follow-up have been proposed; they may be very useful in association with established imaging tools to improve rapid diagnosis and, consequently, outcome. In this review, we will illustrate the most recent proposed biomarkers, their clinical usefulness and future implications for their utilisation.",
author = "C. Cola and S. Trimarchi and A. Mauriello and Eagle, {K. A.} and Giuseppe Sangiorgi",
year = "2006",
month = "6",
language = "English",
volume = "7",
pages = "66--70",
journal = "Cardiology International",
issn = "1468-8581",
publisher = "Greycoat Publishing",
number = "2",

}

TY - JOUR

T1 - New biochemical markers of aortic dissection

AU - Cola, C.

AU - Trimarchi, S.

AU - Mauriello, A.

AU - Eagle, K. A.

AU - Sangiorgi, Giuseppe

PY - 2006/6

Y1 - 2006/6

N2 - The incidence of aortic dissection (AD) ranges from 5 to 30 cases per million people per year. Although the disease is uncommon, its outcome is frequently rapidly fatal. Consequently, the challenge in management of acute AD lies in early diagnosis and timely therapy. Unfortunately, clinical presentation is often misleading: physical findings may be absent or, if present, could be suggestive of other conditions, and therefore the correct diagnosis is missed in up to 40% of patients on initial clinical evaluation. Different diagnostic modalities are now available to improve aortic dissection detection. Spiral CT scanning, MRI and transoesophageal echocardiography are accurate modalities to detect AD with different sensitivity and specificity, but each of these techniques has potential limitations in the evaluation of different clinical-morphological presentation of the disease. Routine laboratory tests have been marginally used so far for AD diagnosis, mostly for differential diagnosis (i.e. myocardial specific enzymes for the exclusion of acute myocardial infarction). Recently, several serum biochemical markers for AD diagnosis and follow-up have been proposed; they may be very useful in association with established imaging tools to improve rapid diagnosis and, consequently, outcome. In this review, we will illustrate the most recent proposed biomarkers, their clinical usefulness and future implications for their utilisation.

AB - The incidence of aortic dissection (AD) ranges from 5 to 30 cases per million people per year. Although the disease is uncommon, its outcome is frequently rapidly fatal. Consequently, the challenge in management of acute AD lies in early diagnosis and timely therapy. Unfortunately, clinical presentation is often misleading: physical findings may be absent or, if present, could be suggestive of other conditions, and therefore the correct diagnosis is missed in up to 40% of patients on initial clinical evaluation. Different diagnostic modalities are now available to improve aortic dissection detection. Spiral CT scanning, MRI and transoesophageal echocardiography are accurate modalities to detect AD with different sensitivity and specificity, but each of these techniques has potential limitations in the evaluation of different clinical-morphological presentation of the disease. Routine laboratory tests have been marginally used so far for AD diagnosis, mostly for differential diagnosis (i.e. myocardial specific enzymes for the exclusion of acute myocardial infarction). Recently, several serum biochemical markers for AD diagnosis and follow-up have been proposed; they may be very useful in association with established imaging tools to improve rapid diagnosis and, consequently, outcome. In this review, we will illustrate the most recent proposed biomarkers, their clinical usefulness and future implications for their utilisation.

UR - http://www.scopus.com/inward/record.url?scp=33744780165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744780165&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:33744780165

VL - 7

SP - 66

EP - 70

JO - Cardiology International

JF - Cardiology International

SN - 1468-8581

IS - 2

ER -